| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chf Gl Pdt Str Officer
1 company
Kyle Jenne is EVP, Chf Gl Pdt Str Officer at IONS. Kyle Jenne's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $958K at current prices.
Our model assigns Kyle Jenne a middling insider score of 51/100, based on 4 past trades. On a 3-month view, 75.0% of the rated trades came out ahead, averaging -4.2% over three months.
The IONS filings lean toward selling, a net 47,018 shares.
Kyle Jenne has 8 Form 4 filings on record from February 2024 to April 2026, all as EVP, Chf Gl Pdt Str Officer at Ionis Pharmaceuticals (IONS), 2024–2026.
The 17 reported transactions were 7 option or other derivative awards, 5 option exercises and 5 open-market sales.
Counted by filing, the open-market trades come to no purchases and 4 sales worth about $3.4M.
The largest open-market sale was 37,277 shares of IONS at an average $75.85 on March 10, 2026, about $2.8M.
1 of the 4 sales since April 2023 was made under a Rule 10b5-1 trading plan; the other 3 were not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | IONS Ionis Pharmaceuticals, Inc. | EVP, Chf Gl Pdt Str Officer | Sale+OE | 4,902 | $75.17 | $368,488.24 | -17.1% | -27.3% | - | |
| Mar 10, 2026 | IONS Ionis Pharmaceuticals, Inc. | EVP, Chf Gl Pdt Str Officer | Sale+OE10b5-1 | 37,277 | $75.85 | $2,827,324.68 | -76.1% | -2.8% | - | |
| Jan 16, 2026 | IONS Ionis Pharmaceuticals, Inc. | EVP, Chf Gl Pdt Str Officer | Sale+OE | 1,823 | $75.96 | $138,475.08 | -10.0% | -1.4% | - | |
| Apr 16, 2025 | IONS Ionis Pharmaceuticals Inc | EVP, Chf Gl Pdt Str Officer | Sale+OE | 3,016 | $28.36 | $85,533.76 | -21.2% | +48.1% | - |